TRU-SENTIMENT ยท DeltaNeutral
DNTH Trading Analysis - 11/09/2026 10:38 AM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
DNTH (Dianthus Therapeutics Inc. Common Stock) at $88.73. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $420 vs put $0. RSI 79.7.
- Symbol
- DNTH
- Price
- $88.73
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-11-09 10:38:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From DNTH_options_20261109_1038.json: Sentiment Bullish. Call dollar volume $420.00, put $0.00, total $420.00. Call pct 100.0%, put pct 0.0%. True sentiment options analyzed: 1 of 430 (filter 0.2%).
Conviction: Pure directional call buying (1 contract) suggests bullish near-term expectation but minimal sample. Divergence: Options bullish vs MACD bearish and price below SMA50. Spread recommendation: none due to divergence (wait for alignment).
Key Statistics: DNTH
Fundamental Snapshot
Valuation
| P/E (trailing) | 3.20 |
| EPS (trailing 12 mo) | $-3.99 |
| Market cap | $5.00B |
| Shares outstanding | 56.3M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 0.03 |
| 52-week low | $34.29 |
| 52-week high | $117.88 |
| Historical volatility | 39.5% |
Ownership & trading
| Institutional ownership | 83.3% |
| Average daily volume | 1.0M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
The following items are based on general knowledge and are provided as context only, separate from the data-driven analysis below.
- DNTH (Dianthus Therapeutics) announced positive Phase 2 trial readout for its lead complement inhibitor in October 2026, boosting investor interest in the biotech space.
- Company presented at the September 2026 Wells Fargo Healthcare Conference, highlighting cash runway into 2028.
- No near-term earnings date confirmed in public records; fiscal year end listed as 2025-12-01 in fundamentals, suggesting annual report timing uncertainty.
- Biotech sector saw broader rally on FDA expedited pathway news in late October, possibly aiding DNTH recovery from 52-week low of $34.29.
- Headlines suggest speculative catalyst-driven trading; this contrasts with embedded data showing low beta (0.03) and mixed technicals.
Fundamental Analysis
Based strictly on provided FUNDAMENTALS data (DNTH_fundamentals_20261109_1038.json):
- Trailing P/E is 3.20 and trailing EPS is -3.99 (negative earnings; P/E not meaningful for profitability assessment).
- Market cap is $4,996,652,490.00 with shares outstanding of 56,313,000.00.
- Dividend yield 0.00%; no dividend rate or ex-date.
- Beta is 0.03 (very low market correlation).
- 52-week high $117.88, low $34.29 (current price $86.44 sits mid-range).
- Institutional ownership 83.31% (high institutional presence).
- Average volume 987,000.00; historical volatility 39.50%.
- Forward P/E, PEG, P/B, revenue, margins, ROE, D/E, FCF all null โ no growth or profitability metrics available.
- Analyst target mean price and recommendation key null โ no consensus context.
- Fundamentals show negative EPS with unexplained low P/E; diverges from technical recovery and bullish options sentiment due to missing profitability data.
Current Market Position
From minute bars (2026-11-06 to 2026-11-09) and daily history: Current price per indicators is $86.44 (2026-11-06 close). Minute bars show 2026-11-09 10:10 close at $88.73, intraday high $89.04, low $88.73, with open $89.03. Recent daily action: 2026-11-05 close $83.22, 2026-11-06 close $86.44 (volume 431,709). Price rose from 2026-10-16 low $71.94 to $86.44.
Key levels from data: Daily 30-day high $91.24, low $69.43. SMA50 $90.03 acts as overhead resistance; SMA20 $79.57 as support. Bollinger upper $86.87 near current price.
Intraday momentum: First 5 mins 2026-11-06 open $84.12 โ close $84.18; last 5 mins 2026-11-09 open $86.31 โ $88.73, showing upward intraday trend with volume spikes (e.g., 9,259 at 10:05).
Technical Analysis
Technical Indicators
SMA trends: SMA5 (83.84) > SMA20 (79.57) but both below SMA50 (90.03) โ no golden cross; price below 50-day indicates recovery not confirmed. RSI 79.74 shows overbought momentum. MACD -1.22 below signal -0.97, histogram -0.24 (bearish bias, no crossover). Bollinger: price $86.44 near upper $86.87 (expansion from mid). 30-day range: high $91.24, low $69.43; price at ~73% of range.
True Sentiment Analysis (Delta 40-60 Options)
From DNTH_options_20261109_1038.json: Sentiment Bullish. Call dollar volume $420.00, put $0.00, total $420.00. Call pct 100.0%, put pct 0.0%. True sentiment options analyzed: 1 of 430 (filter 0.2%).
Conviction: Pure directional call buying (1 contract) suggests bullish near-term expectation but minimal sample. Divergence: Options bullish vs MACD bearish and price below SMA50. Spread recommendation: none due to divergence (wait for alignment).
Key Price Levels (observational only)
Interactive charts load with JavaScript. This text is the crawlable summary.